Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02186431 · ClinicalTrials.gov registry record · NA

Contact Lenses and Infiltrative Keratitis

A NA study, sponsored by State University of New York College of Optometry.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT02186431: Completed NA study, sponsored by State University of New York College of Optometry.

NCT02186431 is a NA study that has completed, run by State University of New York College of Optometry. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02186431, a NA study, has completed, sponsored by State University of New York College of Optometry.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

To quantify and compare baseline tear proteins and ocular response in contact lens wearers with a history of corneal infiltrative events, to those without a history of complications. This will be accomplished via measurement of select anti-inflammatory tear proteins before, during and after contact lens wear.

Interventions

  • DEVICE senofilcon A

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2014-07
Est. Completion 2016-05
Phase NA

What the finished NCT02186431 record still lists

NCT02186431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which senofilcon A is the first listed.

NCT02186431 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02186431 about?

NCT02186431 is a clinical study titled "Contact Lenses and Infiltrative Keratitis". To quantify and compare baseline tear proteins and ocular response in contact lens wearers with a history of corneal infiltrative events, to those without a history of complications. This will be accomplished via measurement of select anti-inflammatory tear proteins before, during and after contact ...

What is the current status of trial NCT02186431?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-07. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02186431?

The interventions under investigation include: senofilcon A (DEVICE).

Who is sponsoring clinical trial NCT02186431?

This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02186431's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02186431, the US trial registry maintained by the National Library of Medicine. NCT02186431 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.